论文信息 - Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib–dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study - 字舞流文

Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib–dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study

R. Greil | R. Foà | I. Yakoub-Agha | X. Leleu | H. Ludwig | M. Engelhardt | M. Baumann | M. Petrucci | C. Leitgeb | L. Garderet | K. Weisel | A. Kruschinski | A. Cafro | D. Zboralski | D. Beyer | K. Riecke | S. Vauléon | T. Dümmler